For M&A groups, a proactive approachfocusing on health-oriented assets, reformulation, and innovationwill be key to navigating and capitalising on this evolving landscape.
Because comparable forms of HGF occur in humans and other mammals, the researchers believe the mechanism could eventually have applications for people as well as companion animals such as cats and dogs, helping preserve mobility, independence, and quality of life during aging or prolonged inactivity
Based on studies suggesting people taking a glucagon-like peptide-1 (GLP-1) could be less likely to develop Alzheimers, Novo Nordisk set up two large trials of its drug, semaglutide sold as the popular diabetes and obesity drugs Ozempic and Wegovy
Beyond the Scale: Non-Scale Victories While the numbers on the scale are an important measure of success, dont overlook the non-scale victories that come with GLP-1 therapy: Increased energy levels and stamina
It is pharmacist reviewed and approved and free of fillers, additives, and preservatives
To a similar end, Endocrine News focuses on a few recent journal studies that take a closer look at the impacts of incretin-based therapies in the setting of obesity and impaired cardiovascular health, as well as how they affect the liver, quality of life, insulin resistance, and much more